Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStomach pains are among the most commonly reported side effects of Mounjaro (tirzepatide). Clinical trial data show gastrointestinal symptoms affected a significant proportion of participants, particularly in the early weeks of treatment and after each dose step up. Most stomach pains on Mounjaro are mild to moderate and settle as your body adjusts — but a small number of symptoms need prompt medical attention. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses your full health picture before it can be prescribed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults and tracked side effects across 72 weeks at different tirzepatide doses. Gastrointestinal events (nausea, vomiting, diarrhoea, constipation, abdominal pain) were the leading reason for discontinuation, yet the vast majority of participants who reported them described them as mild or moderate rather than severe. Stomach pain and discomfort clustered around two predictable moments: the start of treatment and the weeks immediately following a dose increase.
This pattern matters because it tells you something useful. The pain is not random. It reflects how tirzepatide works: as a dual GIP and GLP-1 receptor agonist, it deliberately slows gastric emptying, meaning food sits in the stomach longer before moving on. That delayed transit is part of what reduces appetite and promotes weight loss. It also means the stomach is under more pressure than usual, particularly after a large or fatty meal. The tirzepatide overview on this site goes deeper into the mechanism if you want the fuller picture.
Symptoms most commonly reported alongside stomach pain include nausea, belching, acid reflux and a feeling of fullness that arrives earlier than expected. Most people find these ease considerably within one to two weeks of each dose step, as the gut adapts to the slower transit speed. That settling period does not mean the discomfort should be dismissed, but it does mean it can usually be managed with straightforward adjustments at home.
Several factors reliably make stomach pains on Mounjaro worse. Large portions are the most common culprit: because gastric emptying is already slowed, adding a high-volume meal puts extra load on a stomach that cannot move its contents quickly. Rich, fatty food compounds this. Eating quickly, lying down soon after eating, and skipping water through the day are also frequently associated with more pronounced abdominal discomfort. Our dedicated page on Mounjaro stomach pain explains these triggers in more detail if you want to understand exactly what is driving your symptoms.
Timing of the injection can play a role too. Some people find that injecting earlier in the week gives any nausea or stomach ache time to settle before a busy period, something worth raising with your prescriber if you find symptoms are disruptive. It is the kind of adjustment our prescribers discuss during clinical review.
The guidance on how to take Mounjaro covers injection technique and rotation of sites, which occasionally contributes to localised abdominal discomfort when the abdomen is the chosen injection site. Rotating between the abdomen, thigh and upper arm can help differentiate injection-site soreness from gut-related stomach pain.
People who increase doses without allowing the full recommended period at each step tend to report more intense GI symptoms. Dose titration is set by a prescriber and described in the Patient Information Leaflet for a reason: the gradual approach gives the gut time to acclimatise before the next increase. Never adjust your own schedule, if you feel a dose step is too fast, tell your prescriber.
On 29 January 2026, the MHRA issued a Drug Safety Update for GLP-1 receptor agonist medicines specifically highlighting acute pancreatitis. The update confirmed this as a known, though infrequent, side effect that can be serious. The key symptom pattern to recognise is severe, persistent stomach pain (often starting in the upper abdomen and radiating toward the back) that may come with vomiting and does not settle with simple measures. If you are unsure whether what you are experiencing goes beyond typical digestive upset, our page on bad stomach on Mounjaro helps you distinguish between the expected adjustment symptoms and signs that need prompt attention. This is different from the typical bloating or dull ache associated with dose adjustment.
If you experience that kind of pain, stop eating and seek urgent medical help rather than waiting to see whether it passes. You do not need to diagnose pancreatitis yourself; clinicians will rule it in or out. Gallbladder problems are also a recognised, if uncommon, side effect of GLP-1 medicines and can cause sharp pain in the upper right abdomen, sometimes with nausea after eating fatty food. Upper stomach pain on Mounjaro is covered in more detail in a dedicated page if you want to compare your symptoms against the recognised patterns.
Dehydration from repeated vomiting or diarrhoea is another situation that warrants medical attention rather than self-management. The NHS advises contacting a healthcare professional if you cannot keep fluids down, feel dizzy or faint, or notice significantly reduced urination. You can report suspected side effects at any time via the MHRA Yellow Card scheme, which is open to patients as well as clinicians.
The adjustments that consistently help are not complicated. Eat smaller, more frequent meals rather than one or two large ones. Go easy on fried and fatty foods, at least during the first few weeks of a new dose. Sip water steadily throughout the day rather than drinking large amounts in one go. Sit upright for at least an hour after eating rather than lying down. Avoid carbonated drinks if you find bloating is a particular issue.
Ginger is occasionally mentioned for nausea in general practice settings, and some people find it helpful; there is no specific evidence in the context of Mounjaro, but it is low-risk. Antacids are sometimes used for reflux-type discomfort. What to take and when is a conversation for your prescriber, not something to decide unilaterally, because some over-the-counter medicines interact with absorption timing for daily oral medicines, less relevant for the weekly injection but worth bearing in mind if you are also taking other treatments.
For nights when discomfort is more pronounced, stomach pain at night on Mounjaro is a specific pattern that can have slightly different triggers, including late evening meals and lying flat. If stomach issues are getting in the way of daily life, or persist beyond the first couple of weeks at a dose, that is exactly the kind of thing to raise with your clinical team. Our FAQs cover the most common practical questions people ask during treatment. Aftercare support is available seven days a week, and you can also contact the team directly.
If you are considering Mounjaro for weight management, or want to discuss how stomach symptoms might affect your treatment plan, check your eligibility through a free consultation with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.